Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Interest Expenses (2016 - 2026)

Nutex Health (NUTX) has disclosed Interest Expenses for 14 consecutive years, with $4.7 million as the latest value for Q1 2026.

  • For Q1 2026, Interest Expenses fell 23.5% year-over-year to $4.7 million; the TTM value through Mar 2026 reached $20.8 million, down 3.79%, while the annual FY2025 figure was $22.2 million, 11.51% up from the prior year.
  • Interest Expenses hit $4.7 million in Q1 2026 for Nutex Health, down from $5.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $6.1 million in Q1 2025 and bottomed at $1.9 million in Q1 2022.
  • Average Interest Expenses over 5 years is $4.4 million, with a median of $4.7 million recorded in 2026.
  • Year-over-year, Interest Expenses skyrocketed 455.13% in 2022 and then fell 23.5% in 2026.
  • Nutex Health's Interest Expenses stood at $2.9 million in 2022, then soared by 48.02% to $4.2 million in 2023, then grew by 19.25% to $5.1 million in 2024, then fell by 1.51% to $5.0 million in 2025, then fell by 5.91% to $4.7 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $4.7 million, $5.0 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.